Healthcare -
Biotechnology - NASDAQ - US
$ 5.17
2.64 %
$ 461 M
Market Cap
-1.63
P/E
AMLX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities AMLX - Amylyx Pharmaceuticals, Inc.
75.7 M
LAST VALUE
52.20%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR